experimental drug “Delta-9”

By redbird, December 20, 2014

This drug is teased today as a cure for pain by ENGERY & CAPITAL. they say buy before 12/31 as price will explode. Who are they talking about?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

4
Share your thoughts...

avatar
1 Comment threads
3 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
3 Comment authors
Travis Johnson, Stock GumshoeJim PetersJohn Fenlin Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

jfenlin
Member
πŸ‘11
jfenlin

I have found a stock that has some of these characteristics, GW Pharma (GWPH – ADR), Interestingly the pain medications that may be referred to are cannabinoids. This looks like a super company, up > 600% with a mkt cap of $1.4 billion it cant be the stock were looking for, perhaps there is a royalty recipient for the 2 drugs (I have not tried to tie anything to end of Dec. yet.) Will post relevant links after some more checking. On another topic does anyone know what Wyeth “safe” 16% yielder that goes ex on 12/29 is?

Add a Topic
5971
Add a Topic
5971
Travis Johnson, Stock Gumshoe
Admin
πŸ‘12579

GWPH is one of them — we covered the ad in full here: http://www.stockgumshoe.com/reviews/crows-nest-the/jimmy-mengels-delta-9-is-it-one-drug-to-end-all-pain-naturally/

june41
Member
πŸ‘0
june41

was the person that had the add on your Dec. 19-20 posting. He said he has not missed a prediction in many years. Is his service as good as he says?

Travis Johnson, Stock Gumshoe
Admin
πŸ‘12579

Was that the Harry Dent one? God, no — no one is as good as they say they are, and he’s interesting but often wrong at least in the short term. I expect he’d argue that he’s right in the long term (decades), because his predictions are largely based on demographic trends, but I question how relevant that is for active individual investors. I have not ever seen his paid newsletter, that’s just my impression from occasionally reading his commentary.

Add a Topic
3368
Add a Topic
899